Dosimetric impact of a robust optimization approach to mitigate effects from rotational uncertainty in prostate intensity‐modulated brachytherapy. Issue 2 (29th December 2022)

• Record Type: Journal Article
• Authors: Morén, Björn; Antaki, Majd; Famulari, Gabriel; Morcos, Marc; Larsson, Torbjörn; Enger, Shirin A.; Tedgren, Åsa Carlsson
• Is Part Of: Medical physics. Volume 50:Issue 2(2023)
• Page Start: 1029
• Page End: 1043
• Publication Date: 2022-12-29
• Subjects: high dose‐rate brachytherapy -- inverse treatment planning -- prostate IMBT -- robust optimization; Medical physics -- Periodicals; Medical physics; Geneeskunde; Natuurkunde; Toepassingen; Biophysics; Periodicals; Periodicals; Electronic journals; 610.153
• DOI: 10.1002/mp.16134
• Languages: English
• ISSNs: 0094-2405

Abstract

Abstract: Background: Intensity‐modulated brachytherapy (IMBT) is an emerging technology for cancer treatment, in which radiation sources are shielded to shape the dose distribution. The rotatable shields provide an additional degree of freedom, but also introduce an additional, directional, type of uncertainty, compared to conventional high‐dose‐rate brachytherapy (HDR BT). Purpose: We propose and evaluate a robust optimization approach to mitigate the effects of rotational uncertainty in the shields with respect to planning criteria. Methods: A previously suggested prototype for platinum‐shielded prostate 169 Yb‐based dynamic IMBT is considered. We study a retrospective patient data set (anatomical contours and catheter placement) from two clinics, consisting of six patients that had previously undergone conventional 192 Ir HDR BT treatment. The Monte Carlo‐based treatment planning software RapidBrachyMCTPS is used for dose calculations. In our computational experiments, we investigate systematic rotational shield errors of ±10° and ±20°, and the same systematic error is applied to all dwell positions in each scenario. This gives us three scenarios, one nominal and two with errors. The robust optimization approach finds a compromise between the average and worst‐case scenario outcomes. Results: We compare dose plans obtained from standard models and their robust counterparts. With dwell times obtained from a linear penalty model (LPM), for 10° errors, the dose to urethra ( D 0.1 c c $D_{0.1cc}$ ) and rectum ( D 0.1 c c $D_{0.1cc}$ and D 1 c c $D_{1cc}$ ) increase with up to 5% and 7%, respectively, in the worst‐case scenario, while with the robust counterpart, the corresponding increases were 3% and 3%. For all patients and all evaluated criteria, the worst‐case scenario outcome with the robust approach had lower deviation compared to the standard model, without compromising target coverage. We also evaluated shield errors up to 20° and while the deviations increased to a large extent with the standard models, the robust models were capable of handling even such large errors. Conclusions: We conclude that robust optimization can be used to mitigate the effects from rotational uncertainty and to ensure the treatment plan quality of IMBT.